Drug Repurposing in COVID-19 and Cancer: How Far Have We Come?
- 8 February 2023
- book chapter
- Published by Springer Nature
- p. 519-528
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Drug repurposing: progress, challenges and recommendationsNature Reviews Drug Discovery, 2018
- The Drug Repurposing Hub: a next-generation drug library and information resourceNature Medicine, 2017
- Can you teach old drugs new tricks?Nature, 2016
- Drug repositioning and repurposing: terminology and definitions in literatureDrug Discovery Today, 2015
- Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trialThe Lancet Neurology, 2014
- Topiramate Use Does Not Reduce Flares of Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2014
- Objective assessment of cancer genes for drug discoveryNature Reviews Drug Discovery, 2012
- The rise and fall of DimebonDrug News & Perspectives, 2010
- Molecular epidemiology of human coronavirus OC43 in Hong Kong2007
- In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquineBiochemical and Biophysical Research Communications, 2004